Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004426 · ClinicalTrials.gov registry record · NA
Leuprolide in Determining the Cause of Gonadotropin Deficiency
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00004426 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 90 participants.
The verdict
NCT00004426, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
RATIONALE: The body's response to one injection of leuprolide may provide more information than the standard test for gonadotropin deficiency in determining whether the cause of gonadotropin deficiency is related to the hypothalamus or the pituitary gland. PURPOSE: Randomized double-blinded clinical trial to study the effectiveness of leuprolide in determining the cause of gonadotropin deficiency.
Interventions
- DRUG leuprolide
- DRUG gonadotropin releasing hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 1994-08 |
| Est. Completion | 1998-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004426
The ClinicalTrials.gov registry entry for NCT00004426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which leuprolide is the first listed.
NCT00004426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004426 about?
NCT00004426 is a clinical study titled "Leuprolide in Determining the Cause of Gonadotropin Deficiency". RATIONALE: The body's response to one injection of leuprolide may provide more information than the standard test for gonadotropin deficiency in determining whether the cause of gonadotropin deficiency is related to the hypothalamus or the pituitary gland. PURPOSE: Randomized double-blinded clinica...
What is the current status of trial NCT00004426?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 1994-08. Estimated completion is 1998-09.
What interventions are being tested in trial NCT00004426?
The interventions under investigation include: leuprolide (DRUG), gonadotropin releasing hormone (DRUG).
Who is sponsoring clinical trial NCT00004426?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.